BRUSSELS, Aug 21 (Reuters) - The European Commission clearedon Friday U.S. drugmaker Perrigo's acquisition ofcertain assets from Britain's GSK.
The Commission, in its role as the competition regulator inthe 28-member European Union, said GSK would sell certainproducts such as cold and flu drugs, cold sore and paintreatment products to Perrigo.
"The proposed acquisition would raise no competitionconcerns because of the limited overlaps and the presence ofother strong players on all markets," the Commission said. (Reporting by Robert-Jan Bartunek; Editing by Greg Mahlich)